RGIN News just came out!
Dr. Craig Eagle of the Regenicin Board of Directors Attends The World Stem Cells and Regenerative Medicine Congress 2011
Tuesday June 7, 2011, 10:13 am
LITTLE FALLS, NJ--(Marketwire - 06/07/11) - Regenicin, Inc. (OTC.BB:RGIN - News) announces today that Dr. Craig Eagle who sits on the Regenicin Board of Directors, attended The World Stem Cells and Regenerative Medicine Congress 2011 in efforts to further Regencin's push towards obtaining FDA approval for the commercial sale of its first product candidate.
The World Stem Cells and Regenerative Medicine Congress is a senior director-level, interactive conference experience. Speakers and panelists are industry leaders from throughout Europe, North America and Asia. The World Stem Cells and Regenerative Medicine Congress is Europe's most progressive strategic conference where ideas, intelligence and relationships really make a difference.
"The World Stem Cells and Regenerative Medicine Congress plays a vital role in advancing awareness of the most ground-breaking developments in the field, recognizing key industry leaders, and facilitating top level conversations about strategic planning and partnerships," says Randall McCoy, CEO of Regenicin. "It is great to see that Regenicin is perfectly in line with stem cell technology that is being pursued by the rest of the world."